Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: ɑ1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway

Fig. 3

Correlations between two common GTs and immune infiltration, immunomodulators, immune checkpoints, and immunotherapy. A, B Relationships between ALG3 (A), POMT2 (B) expression and the abundance of 22 immune cell types, analyzed using Pearson correlation analysis. C Correlation between ALG3 or POMT2 expression and 59 immunomodulators. D, E Associations between ALG3 (D) and POMT2 (E) expression and 46 immune checkpoints, evaluating using Pearson correlation analysis. F, G Responsiveness of patients with low- or high-ALG3 (F) or POMT2 (G) expression to immunotherapy, including anti-CTLA-4 and anti-PD1 treatment. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page